Login
$DSX
$2.51 +$0.00 (0.0%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q4 FY2012
As of Dec 31, 2012
ASSETS
Current Assets
Cash and cash equivalents (Note 2(e))
Time deposits (Note 2(e))
Restricted cash, current (Note 2(e) and 8)
Accounts receivable, trade (Note 2(f))
Related Party
Total accounts receivable, trade (Note 2(f))
Due from related parties (Note 4)
Inventories (Note 2(g))
Prepaid expenses and other assets
Investments in equity securities (Note 5(b))
Related Party
Total investments in equity securities (Note 5(b))
Fair value of derivatives
Equity method investment, current (Note 4 (b))
Total Current Assets
Fixed Assets:
Vessels (Note 6)
Accumulated depreciation (Note 6)
Advances for vessel acquisitions (Note 6)
Advances for vessels under construction (Note 6)
Vessels, net (Note 6)
Property and equipment, net (Note 7)
Total fixed assets
Other Noncurrent Assets
Restricted cash, non-current (Note 8)
Due from related parties, non-current (Note 4)
Equity method investments (Note 4)
Investments in a related party (Notes 2(y) and 5(a))
Related Party
Total investments in a related party (Notes 2(y) and 5(a))
Other non-current assets
Deferred costs
Total Non-current Assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Long-term debt, current, net of deferred financing costs (Note 8)
Finance liabilities, current (Note 9)
Accounts payable
Related Party
Total accounts payable
Due to related parties (Note 3)
Accrued liabilities
Deferred revenue
Fair value of derivatives (Note 2(bb) 8)
Total Current Liabilities
Non-current Liabilities
Long-term debt, net of current portion and deferred financing costs (Note 8)
Finance liabilities, net of current portion (Note 9)
Fair value of derivatives (Note 8)
Warrant liability (Note 11(h))
Other non-current liabilities
Total Noncurrent Liabilities
Stockholders' Equity
Preferred stock (Note 11)
Common stock, $0.01 par value; 1,000,000,000 shares authorized and 115,787,434 and 125,203,405 issued and outstanding on December 31, 2025 and 2024, respectively (Note 11)
Additional paid in capital
Accumulated other comprehensive income
Accumulated deficit
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support